Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
基本信息
- 批准号:10681386
- 负责人:
- 金额:$ 331.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAddressAgricultureAppalachian RegionAwardCOVID-19 pandemicCardiovascular systemClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesComplementComputer softwareDedicationsDevelopmentDiabetes MellitusDisciplineDistressEconomicsEngineeringEnvironmentEpidemicFosteringFundingFutureGenerationsGrantGrowthHealthHealth SciencesHealth StatusHealthcareHomeInstitutionIntegrated Health Care SystemsInterventionInvestmentsKentuckyLeadLongevityMalignant NeoplasmsMedicalMedical centerMissionModelingNational Center for Advancing Translational SciencesNeurosciencesObesityParticipantPatientsPersonsPhasePoliciesPopulationPositioning AttributeQuality of lifeReportingResearchResourcesRuralRural CommunityRural HealthScienceSportsSubstance Use DisorderSubstance abuse problemTranslational ResearchTranslationsUnderserved PopulationUnited StatesUniversitiesWest VirginiaWorkaustinclinical centerclinical research sitecollaborative environmentcollegecommunity based participatory researchcommunity engagementdiversity and inclusionhealth disparityhealth equityhealth inequalitiesimprovedinnovationinter-institutionalnew technologyopioid abusepatient engagementprogramsrecruitresponserural area
项目摘要
Contact PD/PI: Kern, Philip A.
PROJECT SUMMARY – OVERALL
The University of Kentucky (UK) Center for Clinical and Translational Science (CCTS) has created an
integrated home for clinical and translational research which promotes scientific progress and discoveries at
every phase of the translational continuum. The CCTS has partnered with communities in Central Appalachia
to address multiple generations of recalcitrant health inequities related in part to the economic distress of rural
communities. The CCTS has fundamentally transformed UK and Central Appalachia through the development
of strong academic-community research networks and collaborations within the CTSA consortium.
Appalachian health disparities are further magnified by the opioid and substance abuse epidemic, which has
greatly impacted eastern Kentucky and West Virginia. The strong UK research portfolio puts the UK CCTS in
an optimal position to lead local, regional and national research efforts focused on rural health inequities.
The aligned missions of UK, UK HealthCare and the CCTS focus on achieving health equity by engaging in
highly innovative, collaborative and dynamic translational research to address rural health needs. The CCTS
will continue to educate the translational workforce of the future, engage rural communities in translational and
bi-directional team science and work with the national network to advance transdisciplinary research and
clinical trials through the following Specific Aims: 1) develop, innovate and transform our research environment
to promote impactful science and discovery within our integrated health care system to meet the unique health
needs of Central Appalachian residents; 2) lead institutional innovation in the delivery of impactful clinical and
translational research that covers the lifespan, fully engages the community and embraces team science; 3)
catalyze an efficient, university-wide clinical trials organization which adds value to the CTSA consortium by
engaging participants from rural Central Appalachia; and 4) foster and enhance a workforce characterized by
diversity and inclusivity across all translational science disciplines and populations. The UK CTSA hub is
uniquely positioned in the National CTSA Consortium to foster novel technologies, team science, clinical trial
start-up and cutting-edge translational research across the lifespan with a focus on rural communities. We
have a particular focus on the Central Appalachian community, a rural area with many of the highest levels of
health disparities in the nation. This focus will ultimately elevate the health and quality of life of rural
communities throughout the United States.
Project Summary/Abstract Page 276
Contact PD/PI: Kern, Philip A.
联系PD/PI:Kern,Philip A.
项目摘要 - 总体
肯塔基大学(英国)临床与转化科学中心(CCTS)创建了一个
综合家庭进行临床和翻译研究,以促进科学进步和发现
翻译连续体的每个阶段。 CCT与阿巴拉契亚中部社区合作
解决与农村经济困扰有关的多代顽固的健康不平等
社区。 CCT从根本上改变了英国和阿巴拉契亚中部。
CTSA财团内的强大学术社区研究网络和合作。
阿片类药物和药物滥用流行病进一步放大了阿巴拉契亚的健康差异
极大地影响了肯塔基州东部和西弗吉尼亚州。强大的英国研究组合将英国CCT置于
领导地方,地区和国家研究工作的最佳立场集中在粗糙的健康不平等上。
英国,英国医疗保健和CCT的一致任务专注于通过参与来实现健康公平
高度创新,协作和动态的转化研究,以满足粗糙的健康需求。 CCT
将继续教育未来的转化劳动力,使农村社区参与转化和
双向团队科学并与国家网络合作,以推进跨学科研究和
通过以下特定目的进行临床试验:1)开发,创新和改变我们的研究环境
在我们的综合卫生保健系统中促进有影响力的科学和发现,以实现独特的健康
阿巴拉契亚中部居民的需求; 2)在提供有影响力的临床和
涵盖寿命,充分吸引社区并拥护团队科学的翻译研究; 3)
催化高效的大学范围临床试验组织,该组织为CTSA联盟增值
吸引来自阿巴拉契亚中部农村地区的参与者; 4)培养和增强以下特征的劳动力
所有转化科学学科和人群的多样性和包容性。英国CTSA枢纽是
独特地位于国家CTSA财团中,以促进新技术,团队科学,临床试验
整个生命周期的启动和尖端的翻译研究,重点是粗糙社区。我们
特别关注阿巴拉契亚中部社区,这是一个崎rough的地区
全国的健康差异。这种重点最终将提高农村的健康和生活质量
美国各地的社区。
项目摘要/摘要页面276
联系PD/PI:Kern,Philip A.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip A Kern其他文献
Philip A Kern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip A Kern', 18)}}的其他基金
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10363388 - 财政年份:2021
- 资助金额:
$ 331.99万 - 项目类别:
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10532229 - 财政年份:2021
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10531210 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
人类米色脂肪组织的激活机制;
- 批准号:
10630687 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10308496 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
The activation of brown and beige fat and role in insulin sensitivity
棕色和米色脂肪的激活及其在胰岛素敏感性中的作用
- 批准号:
9241565 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10185144 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10459638 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
9314011 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10733214 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimizing the implementation of personalized risk-prediction models for venous thromboembolism among hospitalized adults
优化住院成人静脉血栓栓塞个性化风险预测模型的实施
- 批准号:
10658198 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
Center for Virtual Care Value and Equity (ViVE)
虚拟护理价值和公平中心 (ViVE)
- 批准号:
10621602 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
- 批准号:
10747551 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
Learning Precision Medicine for Rare Diseases Empowered by Knowledge-driven Data Mining
通过知识驱动的数据挖掘学习罕见疾病的精准医学
- 批准号:
10732934 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别: